Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStéphanie Lheureux, Amit M. Oza, Ursula A. Matulonis et al.|Clinical Cancer Research|2017Cited by 154
Going to extremes: determinants of extraordinary response and survival in patients with cancerFlurina A.M. Saner, David D.L. Bowtell, Alan Herschtal et al.|Nature reviews. Cancer|2019Cited by 51
Supplementary material from Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStéphanie Lheureux, Amit M. Oza, Zhongwu Lai et al.|Unknown|2023Cited by 0
Supplementary material from Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStéphanie Lheureux, Amit M. Oza, Zhongwu Lai et al.|Unknown|2023Cited by 0
Data from Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStéphanie Lheureux, Amit M. Oza, Zhongwu Lai et al.|Unknown|2023Cited by 0